Search research articles
Contact Us
Filters
Showing results (861-870 of 933) with videos related to
Page
of 94
Sort By:
The Biochemical Journal
|
September 23, 2024
CDS2 expression regulates de novo phosphatidic acid synthesis
Daniel M Collins, Vishnu Janardan, David Barneda, et al.
Plos One
|
January 16, 2020
Potentiation of curing by a broad-host-range self-transmissible vector for displacing resistance plasmids to tackle AMR
Alessandro Lazdins, Anand Prakash Maurya, Claire E Miller, et al.
Hospital Pediatrics
|
October 26, 2022
Characteristics and Outcomes of Children Discharged With Nasoenteral Feeding Tubes
M Alex Ahearn, John R Stephens, Eric K Zwemer, et al.
Annals of Surgical Oncology
|
June 23, 2025
Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma
Kyle R Stephens, Walter R Donica, Prejesh Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis
J P Braybrooke, K J O'Byrne, D J Propper, et al.
Physical Review Letters
|
February 3, 2004
Spatial uniformity of laser-accelerated ultrahigh-current MeV electron propagation in metals and insulators
J Fuchs, T E Cowan, P Audebert, et al.
Chemistry & Biology
|
June 25, 2009
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4
Joakim E Swedberg, Laura V Nigon, Janet C Reid, et al.
Journal of Hospital Medicine
|
June 6, 2023
Safety and predictors of the success of lumbar punctures performed by a medicine procedure service
Andrew Short, Erin Dunneback, John R Stephens, et al.
Ecology
|
March 9, 2017
Global Mammal Parasite Database version 2.0
Patrick R Stephens, Paula Pappalardo, Shan Huang, et al.
Journal of the American Academy of Dermatology
|
August 10, 2025
Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors
Marjan Azin, Parisa Farokh, Alexander McGarry, et al.
Page
of 94
Search research articles
Search
Showing results (861-870 of 933) with videos related to
Sort By:
Page
of 94
The Biochemical Journal
|
September 23, 2024
CDS2 expression regulates de novo phosphatidic acid synthesis
Daniel M Collins, Vishnu Janardan, David Barneda, et al.
Plos One
|
January 16, 2020
Potentiation of curing by a broad-host-range self-transmissible vector for displacing resistance plasmids to tackle AMR
Alessandro Lazdins, Anand Prakash Maurya, Claire E Miller, et al.
Hospital Pediatrics
|
October 26, 2022
Characteristics and Outcomes of Children Discharged With Nasoenteral Feeding Tubes
M Alex Ahearn, John R Stephens, Eric K Zwemer, et al.
Annals of Surgical Oncology
|
June 23, 2025
Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma
Kyle R Stephens, Walter R Donica, Prejesh Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis
J P Braybrooke, K J O'Byrne, D J Propper, et al.
Physical Review Letters
|
February 3, 2004
Spatial uniformity of laser-accelerated ultrahigh-current MeV electron propagation in metals and insulators
J Fuchs, T E Cowan, P Audebert, et al.
Chemistry & Biology
|
June 25, 2009
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4
Joakim E Swedberg, Laura V Nigon, Janet C Reid, et al.
Journal of Hospital Medicine
|
June 6, 2023
Safety and predictors of the success of lumbar punctures performed by a medicine procedure service
Andrew Short, Erin Dunneback, John R Stephens, et al.
Ecology
|
March 9, 2017
Global Mammal Parasite Database version 2.0
Patrick R Stephens, Paula Pappalardo, Shan Huang, et al.
Journal of the American Academy of Dermatology
|
August 10, 2025
Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors
Marjan Azin, Parisa Farokh, Alexander McGarry, et al.
Page
of 94